These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26995076)

  • 21. Induction with intravitreal bevacizumab every two weeks in the management of neovascular age-related macular degeneration.
    Barikian A; Mahfoud Z; Abdulaal M; Safar A; Bashshur ZF
    Am J Ophthalmol; 2015 Jan; 159(1):131-7. PubMed ID: 25308787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aflibercept in the treatment of neovascular age-related macular degeneration in previously treated patients.
    Hall LB; Zebardast N; Huang JJ; Adelman RA
    J Ocul Pharmacol Ther; 2014 May; 30(4):346-52. PubMed ID: 24552305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of Acute Submacular Hemorrhage with Intravitreal Injection of Tenecteplase, Anti-vascular Endothelial Growth Factor and Gas.
    Lee JP; Park JS; Kwon OW; You YS; Kim SH
    Korean J Ophthalmol; 2016 Jun; 30(3):192-7. PubMed ID: 27247518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bevacizumab and triamcinolone acetonide for choroidal neovascularization due to age-related macular degeneration unresponsive to antivascular endothelial growth factors.
    Veritti D; Sarao V; Lanzetta P
    J Ocul Pharmacol Ther; 2013 May; 29(4):437-41. PubMed ID: 23215753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration.
    Emerson MV; Lauer AK; Flaxel CJ; Wilson DJ; Francis PJ; Stout JT; Emerson GG; Schlesinger TK; Nolte SK; Klein ML
    Retina; 2007; 27(4):439-44. PubMed ID: 17420695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Efficacy of Intravitreal Aflibercept in Submacular Hemorrhage Secondary to Wet Age-related Macular Degeneration.
    Shin KH; Lee TG; Kim JH; Kim JW; Kim CG; Lee DW; Han JI; Lew YJ; Cho HJ
    Korean J Ophthalmol; 2016 Oct; 30(5):369-376. PubMed ID: 27729757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration using a variable frequency regimen in eyes with no previous treatment.
    Fong KC; Kirkpatrick N; Mohamed Q; Johnston RL
    Clin Exp Ophthalmol; 2008 Nov; 36(8):748-55. PubMed ID: 19128380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of 12-month treatment of neovascular age-related macular degeneration with intravitreal bevacizumab based on individually determined injection strategies after three consecutive monthly injections.
    Mekjavic PJ; Kraut A; Urbancic M; Lenassi E; Hawlina M
    Acta Ophthalmol; 2011 Nov; 89(7):647-53. PubMed ID: 19860774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.
    Arevalo JF; Fromow-Guerra J; Sanchez JG; Maia M; Berrocal MH; Wu L; Saravia MJ; Costa RA;
    Retina; 2008; 28(10):1387-94. PubMed ID: 18827735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term follow-up after multiple intravitreal bevacizumab injections for exudative age-related macular degeneration.
    Tao Y; Libondi T; Jonas JB
    J Ocul Pharmacol Ther; 2010 Feb; 26(1):79-83. PubMed ID: 20148662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of macular hematoma complicating AMD by vitrectomy, subretinal r-TPA injection, intravitreal injection of bevacizumab combined with gas tamponade: Report of 4 cases].
    Abboud M; Benzerroug M; Milazzo S
    J Fr Ophtalmol; 2017 Feb; 40(2):133-137. PubMed ID: 28189348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of choroidal neovascularization using intravitreal bevacizumab.
    Pedersen R; Soliman W; Lund-Andersen H; Larsen M
    Acta Ophthalmol Scand; 2007 Aug; 85(5):526-33. PubMed ID: 17511757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravitreal ranibizumab for choroidal neovascularization with large submacular hemorrhage in age-related macular degeneration.
    Iacono P; Parodi MB; Introini U; La Spina C; Varano M; Bandello F
    Retina; 2014 Feb; 34(2):281-7. PubMed ID: 23851632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of the frequency of the initial treatment with intravitreal bevacizumab on macular volume and visual acuity.
    Segal O; Mimouni M; Nemet AY; Segev F; Geffen N; Nesher R
    J Ocul Pharmacol Ther; 2015 Jun; 31(5):277-81. PubMed ID: 25853291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravitreous injection of bevacizumab, tissue plasminogen activator, and gas in the treatment of submacular hemorrhage in age-related macular degeneration.
    Guthoff R; Guthoff T; Meigen T; Goebel W
    Retina; 2011 Jan; 31(1):36-40. PubMed ID: 20921929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early treatment of acute submacular haemorrhage secondary to wet AMD using intravitreal tissue plasminogen activator, C3F8, and an anti-VEGF agent.
    de Silva SR; Bindra MS
    Eye (Lond); 2016 Jul; 30(7):952-7. PubMed ID: 27080482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effectivity and safety of bevacizumab intravitreal injections for exudative age-related macular degeneration treatment--6 months observations].
    Małgorzata F
    Klin Oczna; 2010; 112(7-9):213-6. PubMed ID: 21121123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treat-and-extend bevacizumab for neovascular age-related macular degeneration: the importance of baseline characteristics.
    Rush RB; Simunovic MP; Vandiver L; Aragon AV; Ysasaga JE
    Retina; 2014 May; 34(5):846-52. PubMed ID: 24240560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.
    Rich RM; Rosenfeld PJ; Puliafito CA; Dubovy SR; Davis JL; Flynn HW; Gonzalez S; Feuer WJ; Lin RC; Lalwani GA; Nguyen JK; Kumar G
    Retina; 2006; 26(5):495-511. PubMed ID: 16770255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration at twenty-four months: the Pan-American Collaborative Retina Study.
    Arevalo JF; Sánchez JG; Wu L; Berrocal MH; Alezzandrini AA; Restrepo N; Maia M; Farah ME; Brito M; Díaz-Llopis M; Rodríguez FJ; Reategui G; Iturralde-Iraola J; Udaondo-Mirete P;
    Ophthalmology; 2010 Oct; 117(10):1974-81, 1981.e1. PubMed ID: 20569989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.